|Other Names||Inositol polyphosphate multikinase, Inositol 1, 6-tetrakisphosphate 5-kinase, IPMK, IMPK|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP8995c was selected from the Center region of human IPMK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Inositol phosphate kinase with a broad substrate specificity. Has a preference for inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4).|
|Tissue Location||Ubiquitous, with the highest expression in skeletal muscle, liver, placenta, lung, peripheral blood leukocytes, kidney, spleen and colon|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
IPMK is inositol phosphate kinase with a broad substrate specificity. It has a preference for inositol-1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4).
Chang,S.C., et.al., J. Biol. Chem. 277 (46), 43836-43843 (2002)Nalaskowski,M.M., et.al., Biochem. J. 366 (PT 2), 549-556 (2002)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.